Shotgun proteomics: Identification of unique protein profiles of apoptotic bodies from biliary epithelial cells

Ana Lleo, Weici Zhang, W. Hayes McDonald, Erin H. Seeley, Patrick S.C. Leung, Ross L. Coppel, Aftab A. Ansari, David H. Adams, Simon Afford, Pietro Invernizzi, M. Eric Gershwin – 20 May 2014 – Shotgun proteomics is a powerful analytic method to characterize complex protein mixtures in combination with multidimensional liquid chromatography‐tandem mass spectrometry (LC‐MS/MS).

Diabetes mellitus is an independent prognostic factor for major liver‐related outcomes in patients with cirrhosis and chronic hepatitis C

Laure Elkrief, Pascale Chouinard, Noelle Bendersky, David Hajage, Béatrice Larroque, Gérard Babany, Blaise Kutala, Claire Francoz, Nathalie Boyer, Richard Moreau, François Durand, Patrick Marcellin, Pierre‐Emmanuel Rautou, Dominique Valla – 20 May 2014 – In patients with chronic hepatitis C (CHC), cirrhosis is associated with age, gender, diabetes, alcohol abuse, and coinfection with human immunodeficiency virus (HIV) or hepatitis B virus (HBV). The effect of these factors on the outcome of cirrhosis is unknown.

Hepatocytes buried in the cirrhotic livers of patients with biliary atresia proliferate and function in the livers of urokinase‐type plasminogen activator–NOG mice

Hiroshi Suemizu, Kazuaki Nakamura, Kenji Kawai, Yuichiro Higuchi, Mureo Kasahara, Junichiro Fujimoto, Akito Tanoue, Masato Nakamura – 18 May 2014 – The pathogenesis of biliary atresia (BA), which leads to end‐stage cirrhosis in most patients, has been thought to inflame and obstruct the intrahepatic and extrahepatic bile ducts. BA is not believed to be caused by abnormalities in parenchymal hepatocytes. However, there has been no report of a detailed analysis of hepatocytes buried in the cirrhotic livers of patients with BA.

Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: A cohort study using the United Network for Organ Sharing registry

Barry Schlansky, Yiyi Chen, David L. Scott, Donald Austin, Willscott E. Naugler – 18 May 2014 – Recipients of liver transplantation (LT) for hepatocellular carcinoma (HCC) have an 8% to 20% risk of HCC recurrence. Single‐center studies suggest that a period of waiting after HCC therapy may facilitate the selection of patients at low risk for post‐LT HCC recurrence and mortality. We evaluated whether a longer waiting time after Model for End‐Stage Liver Disease (MELD) prioritization for HCC predicts longer post‐LT survival.

Three liver transplants after a single cadaveric procurement: Split liver transplantation plus domino liver transplantation, an infrequent but valid alternative for maximizing transplant sharing and applicability—report of the first Latin American case

Gabriel Gondolesi, Pablo Barros Schelotto, Esteban Halac, Pablo Romero, Marcelo Dip, Guillermo Cervio, Diego Ramisch, Francisco Klein, Silvia Niveyro, Guillermo Orce, Silvina Yantorno, Valeria Descalzi, Oscar Imventarza – 17 May 2014

Subscribe to